(S)-1-(2-((3-methyl-4-((1-methylpiperidin-4-yl)amino)phenyl)amino)pyridin-4-yl)-N-(4-(trifluoromethoxy)benzyl)piperidine-3-carboxamide

ID: ALA4574554

PubChem CID: 155564067

Max Phase: Preclinical

Molecular Formula: C32H39F3N6O2

Molecular Weight: 596.70

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(Nc2cc(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ccn2)ccc1NC1CCN(C)CC1

Standard InChI:  InChI=1S/C32H39F3N6O2/c1-22-18-26(7-10-29(22)38-25-12-16-40(2)17-13-25)39-30-19-27(11-14-36-30)41-15-3-4-24(21-41)31(42)37-20-23-5-8-28(9-6-23)43-32(33,34)35/h5-11,14,18-19,24-25,38H,3-4,12-13,15-17,20-21H2,1-2H3,(H,36,39)(H,37,42)/t24-/m0/s1

Standard InChI Key:  DFVKZHFSOAJABY-DEOSSOPVSA-N

Molfile:  

 
     RDKit          2D

 43 47  0  0  0  0  0  0  0  0999 V2000
   39.4192  -11.2426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4192  -12.0639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1286  -12.4725    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.8380  -12.0639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8380  -11.2426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1286  -10.8298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1281  -13.2930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4147  -13.7010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4143  -14.5215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1267  -14.9351    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.8409  -14.5179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8377  -13.6987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5510  -10.8361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.2616  -11.2467    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.5534  -10.0147    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.9747  -10.8402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6853  -11.2509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6816  -12.0732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.3872  -12.4879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1012  -12.0772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1010  -11.2517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.3906  -10.8448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7023  -14.9339    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.9940  -14.5263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9944  -13.7105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2870  -13.3030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5789  -13.7126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5826  -14.5340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2906  -14.9379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.8087  -12.4863    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   45.8081  -13.3035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.5156  -13.7126    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   45.1001  -13.7116    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   45.8040  -14.1192    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.8701  -13.3059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.8679  -12.4887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5739  -12.0837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5737  -11.2701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8667  -10.8595    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1582  -11.2688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1568  -12.0886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8676  -10.0423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8769  -14.9461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
  5 13  1  6
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  9 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 20 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
 27 35  1  0
 35 36  1  0
 36 37  1  0
 36 41  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 39 42  1  0
 28 43  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4574554

    ---

Associated Targets(Human)

ROS1 Tclin Proto-oncogene tyrosine-protein kinase ROS (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H3122 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC78 (247 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 596.70Molecular Weight (Monoisotopic): 596.3087AlogP: 6.07#Rotatable Bonds: 9
Polar Surface Area: 81.76Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.65CX LogP: 5.71CX LogD: 2.76
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.28Np Likeness Score: -1.65

References

1. Liu S, Jiang Y, Yan R, Li Z, Wan S, Zhang T, Wu X, Hou J, Zhu Z, Tian Y, Zhang J..  (2019)  Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors.,  179  [PMID:31260890] [10.1016/j.ejmech.2019.06.043]

Source